Last reviewed · How we verify
NCT06241638
Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers
NA trial testing Vitamin B12 0.5 MG/ACTUAT in Diabetes Mellitus in 80 participants. Completed in 30 June 2023.
30 June 2023
Quick facts
| Lead sponsor | Al-Balqa Applied University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 80 |
| Start date | 1 July 2022 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 June 2023 |
| Sites | 1 location across Jordan |
Drugs / interventions tested
- Vitamin B12 0.5 MG/ACTUAT — full drug profile →
- Dapagliflozin 10mg Tab — full drug profile →
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Al-Balqa Applied University
Who can join
Adults 18 to 80, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current study was conducted to evaluate the prognostic implications of vitamin B12 admission on BMI and HbA1c levels in type 2 diabetic patients treated with Dapagliflozin as a routine medication.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers, Combined with Dapagliflozin as Type 2 Diabetes Mellitus Routine Treatment: A Controlled Randomized, Double-blind Trial.
Aburayyan W, Zakaraya Z, Hamad M, Majali IS, et al · · 2025 · PMID 40433181 · DOI 10.30476/ijms.2024.101606.3423
Verify or expand the search:
- PubMed search for NCT06241638
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Al-Balqa Applied University trials
Trials by the same sponsor.
- NCT06378879 — Intermittent Boluses Versus Infusion of Propofol During Gastroscopy · NA · not yet recruiting
- NCT04518930 — High Fat vs High Protein and Appetite Hormones · NA · completed
- NCT03310307 — Vitamin D3 Treatment and Homocysteine Concentrations Among Overweight Reproductive Women · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06241638 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Al-Balqa Applied University
- Last refreshed: 2 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06241638.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing